Net Income (Loss) Attributable to Parent in USD of SPRUCE BIOSCIENCES, INC. from Q1 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Spruce Biosciences, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2019 to Q3 2025.
  • Spruce Biosciences, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2025 was -$8.21M, a 5.29% increase year-over-year.
  • Spruce Biosciences, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2025 was -$47.9M, a 21.4% decline year-over-year.
  • Spruce Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$53M, a 10.7% decline from 2023.
  • Spruce Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$47.9M, a 3.77% decline from 2022.
  • Spruce Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$46.2M, a 9.19% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)

SPRUCE BIOSCIENCES, INC. Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$47.9M -$8.21M +$459K +5.29% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-10
Q2 2025 -$48.3M -$2.07M +$7.11M +77.5% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-14
Q1 2025 -$55.5M -$14M -$2.42M -20.8% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-06
Q4 2024 -$53M -$23.6M -$13.6M -137% Oct 1, 2024 Dec 31, 2024 10-K 2025-04-15
Q3 2024 -$39.4M -$8.67M +$3.68M +29.8% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-10
Q2 2024 -$43.1M -$9.18M +$3.64M +28.4% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-14
Q1 2024 -$46.8M -$11.6M +$1.17M +9.12% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-06
Q4 2023 -$47.9M -$9.95M +$1.2M +10.7% Oct 1, 2023 Dec 31, 2023 10-K 2025-04-15
Q3 2023 -$49.1M -$12.4M -$953K -8.36% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$48.2M -$12.8M -$952K -8.02% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 -$47.2M -$12.8M -$1.03M -8.75% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 -$46.2M -$11.1M -$1.96M -21.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-18
Q3 2022 -$44.2M -$11.4M +$46K +0.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$44.3M -$11.9M -$98K -0.83% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$44.2M -$11.8M -$1.88M -19% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$42.3M -$9.18M -$846K -10.1% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-16
Q3 2021 -$41.4M -$11.4M -$1.86M -19.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$39.6M -$11.8M -$5.33M -82.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 -$34.3M -$9.89M -$4.72M -91.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q4 2020 -$29.5M -$8.34M -$5.16M -162% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-14
Q3 2020 -$24.4M -$9.59M -$7.04M -276% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$17.3M -$6.45M -$3.21M -99.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 -$14.1M -$5.17M -$1.05M -25.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q4 2019 -$13.1M -$3.18M Oct 1, 2019 Dec 31, 2019 10-K 2021-03-22
Q3 2019 -$2.55M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-18
Q2 2019 -$3.24M Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-18
Q1 2019 -$4.12M Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-18

SPRUCE BIOSCIENCES, INC. Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$53M -$5.12M -10.7% Jan 1, 2024 Dec 31, 2024 10-K 2025-04-15
2023 -$47.9M -$1.74M -3.77% Jan 1, 2023 Dec 31, 2023 10-K 2025-04-15
2022 -$46.2M -$3.89M -9.19% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-18
2021 -$42.3M -$12.8M -43.2% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-16
2020 -$29.5M -$16.5M -126% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-14
2019 -$13.1M Jan 1, 2019 Dec 31, 2019 10-K 2021-03-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.